Proposed Allosteric Inhibition of Cyclin-Dependent Kinase 4 by a Proline-Derived Acylsemicarbazide Compound with Antiproliferative Activity in Breast Cancer Cells
Xu Huang, Qingyang Nian, Xizhe Sun, Yuheng Zhou, Yuxin Wang, Jiayin Yue, Fanhao Meng, Jingwei Liang · 2026
Read Proposed Allosteric Inhibition of Cyclin-Dependent Kinase 4 by a Proline-Derived Acylsemicarbazide Compound with Antiproliferative Activity in Breast Cancer Cells by Xu Huang, Qingyang Nian, Xizhe Sun, Yuheng Zhou, Yuxin Wang, Jiayin Yue, Fanhao Meng, Jingwei Liang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516810.txt.
Description
Xu Huang and seven colleagues explore a hidden pocket on a cell-cycle protein in a 2026 simulation study. The protein, CDK4, drives cell division and is a proven breast cancer target, yet tumours learn to resist drugs that plug its active site. Using accelerated molecular dynamics and Markov state models, the team watched the protein flex and catalogued shapes. A loop near the active site swung aside in one state, opening a previously unseen side pocket.
A lab-made compound, referred to as 8i, touched a key residue and steadied exactly those pocket-opening shapes. That suggests a way to hobble the protein: not by filling the active site, but by holding the side pocket's door open, an allosteric grip. Huang's team offers the mechanism as a design route toward next-generation CDK4 drugs that might sidestep current resistance. All of this rests on computation, awaiting wet-lab confirmation.
Catalog record
| CREATOR | Xu Huang, Qingyang Nian, Xizhe Sun, Yuheng Zhou, Yuxin Wang, Jiayin Yue, Fanhao Meng, Jingwei Liang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |